chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1.  Severe heartburn that started within 24 hours and lasted about 6 weeks or so. Not currently experiencing the issue.   2.  Heart palpitations mostly when lying down.  Felt like it was skipping a beat.  That was intermittent and last less than a minute at a time.  Has calmed significantly.   3.  I had routine bloodwork done 11 days after vaccine and my cholesterol had jumped from in the 130-140 range to 193.  Retested in June and it is back down to 156.  Went to doctor on April 23, 2021 as routine not a result of any symptoms.  Went to Cardiologist on June 8 because I was concerned about the palpitations (did not feel life threatening but wanted it checked out) and the increase in the cholesterol
Lot # 053E21A was administered outside the 30-day Use by Date. A case was opened with Moderna ID Case ID CEA-1261. "The vaccine administered maintained the activity necessary to protect against the SARS-CoV-2 (Covid-19) virus at time of administration".
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 lot # M005286 with expiration date: 08-OCT-2017, lot # L038522 with expiration date: 11-AUG-2017 (dose and route of administration were not reported). It was also reported that sterile diluent (lot # reported as 00006430900; expiration date and exact dose were not provided) was used. There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 48.6 degrees Fahrenheit. This is one of several reports received from the same reporter. Additional information has been requested.
ringing in ears; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced ringing in ears on an unspecified date. Outcome of the event was unknown.  Information on lot/batch number has been requested.
Twitching events, diagnosed as benign myoclonus of infancy.  Nurse follow up on 10/04/04 states: "Hospital d/c summary and f/u neurology report confirm final diagnosis of benign myoclonus of infancy." Per annual report-at last well check dated 2/15/05 by colleague the child had normal developmental milestones.  It was noted that her "benign myoclonus" had mostly resolved.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 08-JUL-2010, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 21-JAN-2016, the patient was treated for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Received 2nd dose of Pfeizer covid 19 vaccine on 4/24/2021.   4 days after,   she experienced a numnbess of L side of stomach, to L side of back. Near her shoulder blade.    Felt like novacaine.  The sx was steady for 2.5 weeks, then it improved rapidly over the past 2-3  days, and now  It has resolved almost 100% Got both shots L arm.    No ha/ no t dizzy, no sob, no cp, no abdo pain, no n/v/d,  No swelling, no rash.
This spontaneous report as received from a physician refers to a 39 year old female patient. There was no pertinent medical history or drug reactions or allergies. On 08-APR-2013 the patient was vaccinated with (oka/merck) VARIVAX dose 1, 0.5 ml, subcutaneous prophylaxis against varicella. Concomitant therapies included SINGULAIR and an unspecified thyroid supplement. On 14-MAR-2013 the patient experienced rash that was itchy with little bumps and some scabbing over. Patient was treated with BENADRYL and topical cortisone cream. The outcome of rash that was very itchy with little bumps and some scabbing over, was reported as recovering. The relatedness for the adverse event was not reported for SINGULAIR. Additional information has been requested.
Presented with tachycardia; Covid + ED; Admit 9/23 tele with Covid PNA; with 9/23 remdesivir, steroids, singulair, zinc started  9/27 Vit C, Vit D3,   O2: minimal supplemental O2 throughout stay;
This case was reported by a consumer and described the occurrence of injection site erythema in a 73-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included shingles Vaccine (many years ago, received older shingles vaccination with no problems.).  On 31st December 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced injection site erythema, injection site warmth and injection site pain. On an unknown date, the outcome of the injection site erythema, injection site warmth and injection site pain were recovering/resolving. It was unknown if the reporter considered the injection site erythema, injection site warmth and injection site pain to be related to SHINGRIX. Additional details were provided as follows: The fair overall healthy patient received SHINGRIX from the pharmacist at local store. At the time of reporting nearly two weeks later the patient had arm by the injection site was still red and somewhat hot and minor pain. It was far better than it was a few days after the injection. But, the patient concerned the side-effect had lasted this long. The patient asked, what should he do besides waiting.
About 5 minutes after I received the vaccination, I had an allergic reaction. My HR spiked to 175, I felt dizzy and lightheaded, my vision became blurry, and my body started flushing. My eyes also fully dilated. We waited about 30 minutes in the facility and then left as I wanted to take off my mask and get some fresh air. Soon after leaving, I began to feel chest tightness and my throat felt scratchy and I needed to clear it more often. My arms and face were still flushed and felt slightly itchy. Swallowing my drink felt harder. My HR spike again several more times. About two hours after the vaccine, we decided to drive to the ER because the reaction didn't seem to be passing, but seemed to be getting worse slowly.
aches; arm sore; fever; gums in mouth were swollen; This spontaneous case was reported by a consumer and describes the occurrence of GINGIVAL SWELLING (gums in mouth were swollen), PAIN (aches), PAIN IN EXTREMITY (arm sore) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced GINGIVAL SWELLING (gums in mouth were swollen). On an unknown date, the patient experienced PAIN (aches), PAIN IN EXTREMITY (arm sore) and PYREXIA (fever). At the time of the report, GINGIVAL SWELLING (gums in mouth were swollen), PAIN (aches), PAIN IN EXTREMITY (arm sore) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
day p/inject mom reported redness & swelling @ site; pt was instructed to apply local heat & call the next morning if no improvement; p/ 1 wk mom called & said lump still present & red; MD saw pt in the office & prescribed Prelone syrup;
Patient received first Moderna dose on June 8, 2021 and second dose on July 6, 2021. Patient started having flu-like symptoms such as, Fever (but doesn't know what temperature as she did not measure but she felt hot) and chills. After 1-2 days of flu-like symptoms she began to have painfulness around the left arm where she received both of her Moderna vaccines. This painfulness started 3-4 days after receiving the 2nd dose of Moderna vaccine. Patient was also having symptoms of pinching, aches, cramps on left arm along with light-headedness and dizziness. Patient visited the Emergency Department on July 12, 202 and confirmed by the Doctor that there is a blood clot on the left arm. The doctor at the Emergency Department wanted patient to reach out to the pharmacy and report the incident. Patient is currently prescribed for a blood thinner and will follow up with doctors tomorrow 07/15/2021 and another doctor in a week. Patient has allergies to Tree nuts and citrus seeds and was on a birth control Estarylla 0.25-0.035mg tablets until the day she found out that she has a blood clot (07/12/2021).
Inconsolable crying which began immediately, post vax. A follow up report received 4/19/2001 adds: Fever 104 degrees taken by "pacifier thermometer".
Swelling of tongue as of 2/7 - admission to emergency on 2/8 hospital, swelling of lower lip on 2/23 to 2/24 - visit to Allergy Doctor on 2/25 - advised NOT to have second shot
6 - 7 cm oval red, raised area at site of injection left arm covered for possible cellulitis inf - Cephalexin 500mg TID x 1 cd
administered a dose of improperly stored VARN AX; No adverse symptoms were reported; This non-valid spontaneous report was received from a medical assistant and refers to a multiple patients of an unknown age and gender. There was no information about the patients' concurrent conditions, concomitant medication and medical history provided.  On an unknown dates, the patients were vaccinated with a doses of improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) lot number: S038177, expiration date: 26-NOV-2021, for prophylaxis (exact dose and route of administration were not reported). The vaccines were reconstituted with properly stored sterile diluent.  The vaccines experienced temperature excursion of -14 degrees Celsius to -10 degrees Celsius (-13 degrees Celsius) for 24 minutes. Previous temperature excursion was detected and it was from -14 degrees Celsius to -10 degrees Celsius (-10.4 degrees Celsius) for 29 minutes. The digital data logger was involved.  The report is non-valid due to lack of the patients' identifiers.
death Narrative: pt had first vaccine on 1/26; caregiver declined second dose due to concerns of side effects; pt died 3/29/21 (not from COVID)
This spontaneous report was received from a physician referring to an adult patient of unknown gender. The patient's concurrent conditions and medical history were not provided. On an unknown date, the patient was vaccinated with PROQUAD. Concomitant therapies were not provided. No adverse events were reported. No product quality complaint was involved. This is one of several reports received from the same source. Additional information has been requested.
Patient received PNEUMOVAX 23 in clinic and presented to primary care provider the following day with fever and rash. Patient denied any s/sx of troubled breathing. Patient quickly became hypotensive while in clinic w/ c/o dizziness w/o loss of consciousness. IM triamcinolone and  dexamethasone was administered in clinic and patient was quickly transferred to ED for further treatment. Patient received IV fluids in ED, which allowed BP to recover and normalize. Difficult to determine if episode was a hypersensitivity type reaction of or  if the patient had underlying dehydration. As the patient's BUN:SCr BUN:SC  ratio was <20, it's difficult to r/o PNEUMOVAX 23 as cause of hypotension.
dull pain in stomach; presented nausea and vomiting; presented nausea and vomiting; sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of APPENDICITIS (dull pain in stomach) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included LEVOTHYROXINE for an unknown indication.    On 18-Mar-2021 at 3:40 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced APPENDICITIS (dull pain in stomach) (seriousness criterion hospitalization). 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 19-Mar-2021, the patient experienced NAUSEA (presented nausea and vomiting) and VOMITING (presented nausea and vomiting). On 19-Mar-2021, APPENDICITIS (dull pain in stomach) had resolved. At the time of the report, NAUSEA (presented nausea and vomiting) and VOMITING (presented nausea and vomiting) had resolved and PAIN IN EXTREMITY (sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Computerised tomogram: abnormal (abnormal) CT abdomen showed Inflamed appendix. Appendicitis was diagnosed..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   From the ER, the CAT scan was performed, diagnosed with appendicitis and emergency appendectomy was done on 19-MAR-2021.  Patient was discharged on docusate sodium, Ibuprofen, hydrocodone for surgical pain.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-062603 (E2B Linked Report).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. MOD-2021-062603:
Patient describes that the injection site is red, hot, swollen, and painful. The swollen and red spot is approximately 2 inches in diameter according  to a picture that the patient sent us via a message. Patient advised us that she had a fever on Tuesday, 1/7/2020. She had received the vaccine on 1/6/2020. Pt stated that her arm has been painful since receiving the vaccine. Patient had been given the pneumonia and flu vaccines in the same arm.  Pt was advised by Dr. to ice the injection site and take tylenol/ibuprofen to help with the pain. Also advised by PA to treat with compresses and anti-inflammatories, such as 800 mg ibuprofen 3 times daily and alternate with Tylenol between ibuprofen doses. Patient was informed to call us if no improvement or worsening in the next few days. Patient was offered to have a letter witten for her to have time off of work if she would like due to the reaction.
I was positive for Covid-19 I had a headache; sore throat and runny nose.
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. On 16-OCT-2014, the patient was vaccinated with improperly stored dose of RECOMBIVAX HB (dose, route and lot # unknown). No adverse effects reported. Doses of GARDASIL and PNEUMOVAX were also stored improperly, but none of these doses were administered to patients. Additional information is not expected as the nurse cannot be contacted.
Tenderness on arm; This is a spontaneous report from a contactable consumer (reporting for her husband).  A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date (age at vaccination unknown) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had tenderness on his arm, that was it. He didn't experience any other side effects. The clinical outcome of tenderness on his arm was unknown.   Information on the lot/batch number has been requested.
short term memory loss; lost sense of taste; A spontaneous report was received from a concerning male patient of 67 years old, who was administered with Moderna's COVID-19 vaccine for prophylaxis of COVID-19 infection. On 18-FEB-2021, patient received the first dose of mRNA-1273 vaccine. The patient's medical history was not provided.  Concomitant medications were not provided by the patient.  Patient experienced the adverse event such as short term memory loss, lost sense of taste and stated that these events were not reported prior to the vaccine administration.  The treatment for the adverse events was not provided by the patient.  Action taken with the dose of mRNA-1273 vaccine was not reported. Consent to follow up from safety was provided by the patient.
04jun90 pt vax 2nd hepta B. pt devel severe itching, redness and soreness at inject site. sx remitted spon. in 24hrs.
pt recvd vax & devel a wheat & flare @ the inject site which was described as white welts in a flat red area;
Within 24 hours of receiving the Moderna booster I became very ill with extreme body aches - joints and muscular. This lasted for 48 hours until I began taking 800 mg of Ibuprofen. I also experienced extreme fatigue, sleeping 10-12 hours a day. I didn't feel well with the first vaccination, was fine with the 2nd vaccination, but this was the worst I had experienced. By the 4th day, the pain was manageable with 800mg of Ibuprofen every 12 hours, but fatigue continues. Starting 24 hours after the shot, my left arm/shoulder had swollen glands all around to the point I couldn't use my arm and felt like I needed a sling to find relief standing because it was painful to hang at my side. The most concerning issue is that despite my menstrual cycle being regular and just ending six days prior, by the 4th day after the shot, my breasts became extremely sore, swollen, and I began cramping. On the 5th day, it's as if I'm having another menstrual cycle with bleeding and cramps. I've also gained six pounds despite not having much of an appetite that seems related to fluid retention. I'm now on the 8th day since my shot, menstruating, swollen, joints aching, and extreme fatigue and brain fogginess.
Nausea; Super tired; very very sore left arm; Body aches; Very severe headache; Vomiting; This spontaneous case was reported by a patient and describes the occurrence of NAUSEA (Nausea), FATIGUE (Super tired), PAIN IN EXTREMITY (very very sore left arm), MYALGIA (Body aches) and HEADACHE (Very severe headache) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 021H22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Patient reported no other health issues.  Concurrent medical conditions included Cholesterol blood excessive. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for Cholesterol blood excessive.    On 21-Feb-2023, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In February 2023, the patient experienced NAUSEA (Nausea), FATIGUE (Super tired), PAIN IN EXTREMITY (very very sore left arm), MYALGIA (Body aches), HEADACHE (Very severe headache) and VOMITING (Vomiting). The patient was treated with PARACETAMOL (TYLENOL) on 23-Feb-2023 for Headache, at an unspecified dose and frequency. At the time of the report, NAUSEA (Nausea) and FATIGUE (Super tired) had not resolved, PAIN IN EXTREMITY (very very sore left arm), MYALGIA (Body aches) and HEADACHE (Very severe headache) outcome was unknown and VOMITING (Vomiting) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 degrees Fahrenheit.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Patient had never received another vaccine within 4 weeks of any of the Moderna Covid-19 vaccines.  It was reported that the patient was still very nauseous and very tired, however, patient was able to hold down some chicken broth and noodle soup as the patient could not keep food down for 24 hours.   This case was linked to MOD-2023-712853 (Patient Link).
chest pain, diaphoresis, incontinence, N/V, dizziness; symptoms are no longer occuring after be treated and released from hospital 2/3/21
Dizziness; Headache; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 17Mar2021 at 19:00 (at the age of 39-years-old) as single dose for COVID-19 immunisation. No relevant medical history and concomitant medication was reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 24Mar2021 (approximately one week after the vaccine), the patient experienced headache, dizziness and swollen lymph nodes. The patient did not receive any treatment for the events experienced. The adverse events did not result in a doctor or other healthcare professional office/clinic visit/ emergency visit. The clinical outcomes of the events headache, dizziness and swollen lymph nodes were resolving at the time of this report.   Information about lot number cannot be obtained. No further information expected.
severe rash on abdomen, sides and back, itchy red bumps; severe rash on abdomen, sides and back, itchy red bumps; severe rash on abdomen, sides and back, itchy red bumps; This is a spontaneous report from a contactable consumer (patient). A 73-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL3249), via an unspecified route of administration on 17Jan2021 12:45 at single dose in right arm for COVID-19 immunisation. The patient was vaccinated at hospital. Patient age at time of vaccination was 73 years. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history included congestive heart failure and atrial fibrillation. The patient had no allergies to medications, food, or other products. Concomitant medications included acetylsalicylic acid (ASPIRIN), atorvastatin, duloxetine, apixaban (ELIQUIS), hydralazine hydrochloride (HYDRALAZIN). On 21Jan2021 the patient had a severe rash on abdomen, sides and back; itchy, red bumps. The events were reported as non serious. The events had not resolved. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19.